Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450775 · ClinicalTrials.gov registry record · Phase 4
Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00450775 is a Phase 4 study that has completed, run by Innovative Medical. The registered enrollment target is 12 participants.
The verdict
NCT00450775, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and patient acceptance of Dermatix Q for the prevention and treatment of scarring.
Interventions
- DRUG Dermatix Q
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00450775
The ClinicalTrials.gov registry entry for NCT00450775 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dermatix Q is the first listed.
NCT00450775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00450775 about?
NCT00450775 is a clinical study titled "Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars". The purpose of this study is to evaluate the efficacy and patient acceptance of Dermatix Q for the prevention and treatment of scarring.
What is the current status of trial NCT00450775?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2007-03. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00450775?
The interventions under investigation include: Dermatix Q (DRUG).
Who is sponsoring clinical trial NCT00450775?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.